blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1754058

EP1754058 - Method for determining the amount of circulating CD36 [Right-click to bookmark this link]
Former [2007/08]METHOD OF EVALUATION OF THE RELATIVE RISK OF DEVELOPING ATHEROSCLEROSIS IN PATIENTS
[2015/21]
StatusNo opposition filed within time limit
Status updated on  17.02.2017
Database last updated on 11.09.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG		published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
Region Nordjylland
Niels Bohrs Vej 30
9220 Aalborg Øst / DK
[2013/13]
Former [2007/08]For all designated states
Atherocheck APS
c/o Ostjysk Innovation A/S Gustav Wieds Vej 10
8000 Arthus C / DK
Inventor(s)01 / Handberg, Aase
Permelillevej 15
8240 Risskov / DK
 [2013/13]
Former [2007/08]01 / see applicant
...
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[N/P]
Former [2016/15]Høiberg A/S
St. Kongensgade 59 A
1264 Copenhagen K / DK
Former [2007/08]HOEIBERG A/S
European Patent & Trademark Attorneys Store Kongensgade 59A
1264 Copenhagen K / DK
Application number, filing date05744476.226.05.2005
[2007/08]
WO2005DK00352
Priority number, dateDK2004000082926.05.2004         Original published format: DK 200400829
DK2004000122213.08.2004         Original published format: DK 200401222
US20040601123P13.08.2004         Original published format: US 601123 P
[2007/08]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005116644
Date:08.12.2005
Language:EN
[2005/49]
Type: A2 Application without search report 
No.:EP1754058
Date:21.02.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 08.12.2005 takes the place of the publication of the European patent application.
[2007/08]
Type: B1 Patent specification 
No.:EP1754058
Date:13.04.2016
Language:EN
[2016/15]
Search report(s)International search report - published on:EP21.12.2006
ClassificationIPC:G01N33/68
[2015/21]
CPC:
G01N33/6893 (EP); G01N2333/70596 (EP)
Former IPC [2007/08]G01N33/50
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/15]
Former [2007/08]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL21.06.2007
BA21.06.2007
HR21.06.2007
LV21.06.2007
MK21.06.2007
YU21.06.2007
TitleGerman:Verfahren zur Bestimmung der Menge von zirkulierendem CD36[2015/21]
English:Method for determining the amount of circulating CD36[2015/21]
French:Procédé pour déterminer la quantité de CD36 circulant[2015/21]
Former [2007/08]VERFAHREN ZUR BEURTEILUNG DES RELATIVEN RISIKOS DER ENTWICKLUNG VON ATHEROSKLEROSE IN PATIENTEN
Former [2007/08]METHOD OF EVALUATION OF THE RELATIVE RISK OF DEVELOPING ATHEROSCLEROSIS IN PATIENTS
Former [2007/08]PROCEDE POUR EVALUER LE RISQUE RELATIF DE DEVELOPPEMENT DE L'ATHEROSCLEROSE CHEZ DES PATIENTS
Entry into regional phase27.12.2006National basic fee paid 
21.06.2007Designation fee(s) paid 
21.06.2007Examination fee paid 
Examination procedure13.02.2007Amendment by applicant (claims and/or description)
21.06.2007Examination requested  [2007/31]
12.08.2008Despatch of a communication from the examining division (Time limit: M04)
11.12.2008Reply to a communication from the examining division
14.04.2010Despatch of a communication from the examining division (Time limit: M06)
26.11.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
31.01.2011Reply to a communication from the examining division
28.08.2012Despatch of a communication from the examining division (Time limit: M04)
27.12.2012Reply to a communication from the examining division
24.04.2014Despatch of a communication from the examining division (Time limit: M04)
12.08.2014Reply to a communication from the examining division
18.05.2015Communication of intention to grant the patent
28.09.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
28.09.2015Fee for grant paid
28.09.2015Fee for publishing/printing paid
21.10.2015Communication of intention to grant the patent
22.02.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.08.2008
Opposition(s)16.01.2017No opposition filed within time limit [2017/12]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
31.01.2011Request for further processing filed
31.01.2011Full payment received (date of receipt of payment)
Request granted
08.02.2011Decision despatched
Fees paidRenewal fee
31.05.2007Renewal fee patent year 03
02.06.2008Renewal fee patent year 04
02.06.2009Renewal fee patent year 05
31.05.2010Renewal fee patent year 06
25.05.2011Renewal fee patent year 07
18.05.2012Renewal fee patent year 08
01.05.2013Renewal fee patent year 09
06.05.2014Renewal fee patent year 10
12.05.2015Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.05.2005
AT13.04.2016
BE13.04.2016
BG13.04.2016
CY13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
IS13.04.2016
LT13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
TR13.04.2016
LU26.05.2016
GR14.07.2016
PT16.08.2016
[2018/38]
Former [2018/32]HU26.05.2005
AT13.04.2016
BE13.04.2016
CY13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
IS13.04.2016
LT13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
TR13.04.2016
LU26.05.2016
GR14.07.2016
PT16.08.2016
Former [2018/29]HU26.05.2005
AT13.04.2016
BE13.04.2016
CY13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
LT13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
TR13.04.2016
LU26.05.2016
GR14.07.2016
PT16.08.2016
Former [2018/28]HU26.05.2005
AT13.04.2016
BE13.04.2016
CY13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
LT13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/37]AT13.04.2016
BE13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
LT13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/10]AT13.04.2016
BE13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
LT13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SK13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/09]AT13.04.2016
BE13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
LT13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/07]AT13.04.2016
BE13.04.2016
DK13.04.2016
FI13.04.2016
LT13.04.2016
MC13.04.2016
PL13.04.2016
SE13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/03]AT13.04.2016
BE13.04.2016
FI13.04.2016
LT13.04.2016
PL13.04.2016
SE13.04.2016
GR14.07.2016
PT16.08.2016
Former [2016/52]AT13.04.2016
FI13.04.2016
LT13.04.2016
PL13.04.2016
SE13.04.2016
BE31.05.2016
GR14.07.2016
PT16.08.2016
Former [2016/51]AT13.04.2016
FI13.04.2016
LT13.04.2016
PL13.04.2016
BE31.05.2016
GR14.07.2016
PT16.08.2016
Former [2016/50]AT13.04.2016
FI13.04.2016
LT13.04.2016
PL13.04.2016
BE31.05.2016
Former [2016/49]FI13.04.2016
LT13.04.2016
PL13.04.2016
BE31.05.2016
Former [2016/46]LT13.04.2016
BE31.05.2016
Former [2016/37]BE31.05.2016
Cited inInternational search[XY]JP2000180447  ;
 [XY]JP2001056338  ;
 [A]WO2004017986  (UNIV MONTREAL [CA], et al) [A] 9-14,9-14,9-14 * the whole document * * the whole document * * the whole document *;
 [A]WO0136675  (ISIS INNOVATION [GB], et al) [A] 9-14,9-14,9-14 * the whole document * * the whole document * * the whole document *;
 [A]US6322976  (AITMAN TIMOTHY J [GB], et al) [A] 9-14,9-14,9-14 * the whole document * * the whole document * * the whole document *
 [XY]  - PATENT ABSTRACTS OF JAPAN, (20001013), vol. 2000, no. 09, & JP2000180447 A 20000630 (DAINIPPON PHARMACEUT CO LTD) [X] 1-4,7,8,1-4,7,8,1-4,7,8 * abstract * * abstract * * abstract * [Y] 5,6,15,5,6,15,5,6,15
 [XY]  - PATENT ABSTRACTS OF JAPAN, (20010605), vol. 2000, no. 19, & JP2001056338 A 20010227 (TOKYOTO IGAKU KENKYU KIKO; KASANUKI HIROSHI; IATRON LAB INC) [X] 1-4,1-4,1-4 * abstract * * abstract * * abstract * [Y] 5,6,15,5,6,15,5,6,15
 [AY]  - PELSERS M M A L ET AL, "A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: Abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes", BIOCHEMICAL JOURNAL, PORTLAND PRESS, LONDON, GB, (19990201), vol. 337, no. 3, ISSN 0264-6021, pages 407 - 414, XP002341307 [A] 9-14,9-14,9-14 * the whole document * * the whole document * * the whole document * [Y] 5,6,15,5,6,15,5,6,15

DOI:   http://dx.doi.org/10.1042/0264-6021:3370407
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.